Navigation Links
Fovea Reports Positive Results with Prednisporin(TM) in Persistent Allergic Conjunctivitis
Date:5/4/2009

PARIS, May 4 /PRNewswire/ -- Fovea Pharmaceuticals announced today positive results from its clinical proof-of-concept trial to assess the therapeutic effect of Prednisporin(TM) (FOV1101) in patients with persistent allergic conjunctivitis.

Prednisporin(TM) had the same efficacy and a better safety profile (no increase in intra-ocular pressure) than PredForte(TM), a prescription drug with a 10 fold higher dose of prednisolone acetate, in patients treated for the signs and symptoms (itching and redness) of persistent ocular allergic inflammation. A one-week pre-treatment with Pataday(TM) (an anti-histamine) had negligible effect on these parameters in this patient population.

The prospective, multicenter, randomized, double masked, bilateral comparison study with 150 patients was conducted by Ora Inc., in the USA utilizing Ora's Enviro-CAC(TM) clinical technology. The combination therapy of low doses cyclosporine A and prednisolone acetate was compared to PredForte(TM) alone or vehicle alone during a 2-week dosing period.

"We are extremely pleased with these results, and they are totally in line with our expectations," said Bernard Gilly, Chairman and Chief Executive Officer of Fovea. "We believe that Prednisporin(TM) has the potential to provide safe and effective therapy to millions of patients suffering from chronic inflammatory conjunctivitis, a complex indication, that is not addressed by existing treatments."

Prednisporin(TM) is the first combination therapy developed for the treatment of persistent allergic conjunctivitis. It is a proprietary topical formulation of lower than the usual therapeutic doses prednisolone acetate and cyclosporine A, to retain the efficacy of a very potent steroid with an improved safety profile. The concept was first discovered and patented by CombinatoRx (Nasdaq: CRXX
'/>"/>

SOURCE Fovea Pharmaceuticals
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Fovea Pharmaceuticals Receives Orphan Drug Designation from EC for RdCVF for the Treatment of Retinitis Pigmentosa
2. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
3. Spherix Reports Second Quarter Earnings
4. Tapestry Reports Second Quarter 2007 Results
5. Callisto Reports on Second-Quarter 2007 Milestones
6. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
7. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
8. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
9. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
10. Biopure Reports on Meeting with the FDA
11. Peregrine Reports Data Showing Bavituximabs Potential to Shrink Prostate Tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... According to a new ... Management Market ECG, Implantable Loop Recorder, Manual Event ... Dual Chamber Pacemaker, CRT-D, CRT-P - Global Forecast ... Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices ... 2020 from $21,137.7 Million in 2015, at a ...
(Date:7/3/2015)... , July 3, 2015 ... bekannt, vorbehaltlich bestimmter Abschlussbedingungen eine 100-prozentige Beteiligung ... zu haben. Mit dieser Übernahme dringt Lupin ... einem Umsatz von 765 Mrd. RUB im ... der Welt gehörte (IMS Health). Seit über ...
(Date:7/2/2015)... 2015 Pharma Major Lupin ... participación en ZAO "Biocom" en Rusia bajo ciertas ... de Lupin en el mercado farmacéutico de Rusia ... colocándolo como uno de los 10 principales mercados ... más de una década, el mercado farmacéutico ruso ...
Breaking Medicine Technology:Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 2Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 3Cardiac Monitoring (CM) and Cardiac Rhythm Management (CRM) Devices Market Worth $26,646.5 Million by 2020 4Lupin übernimmt Biocom aus Russland 2Lupin übernimmt Biocom aus Russland 3Lupin adquiere Biocom en Rusia 2Lupin adquiere Biocom en Rusia 3
... 2, 2011 Cynosure, Inc. (NASDAQ: CYNO ), ... and non-invasive aesthetic applications, today announced that it will present ... (ET) on Thursday, June 9 in New York City. ... Davin and Executive Vice President, Treasurer and CFO Timothy Baker ...
... (NASDAQ: BNVI ), a pharmaceutical company focused on ... women,s health and cancer, today announced it will be presenting ... drug candidate for postmenopausal symptoms, Menerba ™ (also known ... World Congress on Menopause in Rome, Italy on June 11, ...
Cached Medicine Technology:Bionovo to Present the Clinical Promise of Menerba (MF101) for Postmenopausal Vasomotor Symptoms at World Congress on Menopause 2Bionovo to Present the Clinical Promise of Menerba (MF101) for Postmenopausal Vasomotor Symptoms at World Congress on Menopause 3Bionovo to Present the Clinical Promise of Menerba (MF101) for Postmenopausal Vasomotor Symptoms at World Congress on Menopause 4
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... Scientists at ... susceptible to mesothelioma with even minimal asbestos exposure. Click here to read the ... the University of Hawaii Cancer Center, Cedars Sinai Medical Center, and New York University ...
(Date:7/3/2015)... ... ... Smoothies are all the rage right now and all you need to make ... is proud to introduce a new line of all natural products that blend right ... , Aurora is offering a variety of blends and stand-alone items to choose from. ...
(Date:7/3/2015)... ... July 03, 2015 , ... Yisrayl Hawkins, Pastor and Overseer ... week that he says will reveal biblical truth and expose popular lies regarding proper ... Bible Say Don’t Have Sex”, immediately goes into the core of the subject by ...
(Date:7/2/2015)... ... July 02, 2015 , ... sweetFrog Enterprises, LLC. is pleased to announce the ... sweetFrog store located in the Lone Star State. The premium frozen yogurt chain was ... , The store, which opened July 1 at Duke’s Travel Plaza, is located at:, ...
(Date:7/2/2015)... ... July 02, 2015 , ... With summer in full swing, Americans are flocking to Canada’s ... the top spots for fishing in the world, and it’s easy to understand why. From ... has great fish. , Recreational fishing is a huge industry, and Americans make up ...
Breaking Medicine News(10 mins):Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2Health News:Aurora Product, Inc. Announces An Original New Line: Smoothie Fixins’ 2Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2Health News:sweetFrog Expands Texas Footprint with Location in Canton 2
... Nottingham are hoping to find out if inflammation of the ... condition which leads to pain, stiffness, swelling and disability. ... osteoarthritis in the knee. Now 200 patients, over the ... take part in a study led by research physiotherapist Michelle ...
... Network today announced that several leading commercial providers ... manufacturing sites with the network. SNM,s Clinical Trials ... need for streamlined drug discovery through the integration ... According to Michael M. Graham, M.D., Ph.D., SNM ...
... FORT WORTH, Texas and AUSTIN, Texas, July 23 RadioShack ... with seven-time Tour de France winner Lance Armstrong to form a new ... for Team RadioShack as a cyclist, runner and triathlete in events around ... , Lance Armstrong returned to the world stage of professional ...
... can be, experts say , THURSDAY, July 23 (HealthDay News) ... represents in the world of science is anything but that. ... Tiny,s brethren) marks a milestone in stem cell research: Healthy, ... not from embryonic cells, but rather cells sourced from adult ...
... , American Academy ... ROSEMONT, Ill., July 23 The American Academy of Orthopaedic ... organization dedicated to collecting and reporting on hip and knee joint replacement ... , , The goal of a ...
... and coronary function are restored , THURSDAY, JULY 23 ... heart tissue renew itself after a heart attack -- until ... blood to the heart become blocked, preventing enough oxygen from ... , But researchers at Children,s Hospital Boston report progress toward ...
Cached Medicine News:Health News:Detecting early signs of osteoarthritis 2Health News:SNM's Clinical Trials Network expands European membership of PET biomarker manufacturers 2Health News:RadioShack Partners With Seven-Time Tour de France Winner Lance Armstrong to Form New Cycling Team in 2010 2Health News:RadioShack Partners With Seven-Time Tour de France Winner Lance Armstrong to Form New Cycling Team in 2010 3Health News:RadioShack Partners With Seven-Time Tour de France Winner Lance Armstrong to Form New Cycling Team in 2010 4Health News:Scientists Use Non-Embryonic Stem Cells to Create Healthy Mice 2Health News:Scientists Use Non-Embryonic Stem Cells to Create Healthy Mice 3Health News:American Joint Replacement Registry Announced 2Health News:Injection May Heal Damaged Heart 2
Inquire...
... Series 2000 Pipette is a synonym for ... and robust design, and superior operating comfort. ... operate the measuring stroke and blow-out as ... "pipette/tip" system ensures utmost accuracy and precision. ...
... new Finnpipette Focus from Thermo ... combine ergonomics with uncompromising performance. ... plate offers a custom fit ... new shorter tip cones allow ...
... A fixed pipette is ideal ... single volume. Fixed volume FInnpipettes ... advantages as other Finnpipette Digital ... Super blow-out (1-40ul), Soft-touch tip ...
Medicine Products: